PUBLICATIONS · 28819011
TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Blood
- Publication date
- 2017 Oct 26
- First author
- Eskelund CW
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Blood. 2017 Oct 26;130(17):1876-1877. doi: 10.1182/blood-2017-08-803551.
- note
- Source null
- related pmid
- 29074593
- relationship
- Comment in
Authors and identifiers
- name
- Eskelund CW
- type
- Author
- name
- Dahl C
- type
- Author
- name
- Hansen JW
- type
- Author
- name
- Westman M
- type
- Author
- name
- Kolstad A
- type
- Author
- name
- Pedersen LB
- type
- Author
- name
- Montano-Almendras CP
- type
- Author
- name
- Husby S
- type
- Author
- name
- Freiburghaus C
- type
- Author
- name
- Ek S
- type
- Author
- name
- Pedersen A
- type
- Author
- name
- Niemann C
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Eskelund CW
- type
- Author
- name
- Dahl C
- type
- Author
- name
- Hansen JW
- type
- Author
- name
- Westman M
- type
- Author
- name
- Kolstad A
- type
- Author
- name
- Pedersen LB
- type
- Author
- name
- Montano-Almendras CP
- type
- Author
- name
- Husby S
- type
- Author
- name
- Freiburghaus C
- type
- Author
- name
- Ek S
- type
- Author
- name
- Pedersen A
- type
- Author
- name
- Niemann C
- type
- Author
- bibliography ids
- nci-bib-abd98cde45116350dfab8b6e
- book metadata
- content sha256
- 04b609ae7db4addec24352a379cd167d5b149c6ef502ae16fe6ed131a71cc489
- document type
- citation
- dois
- 10.1182/blood-2017-04-779736
- electronic publication date
- display
- 2017 Aug 17
- precision
- day
- year
- 2017
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:28819011
- immutable id
- pubmed:28819011@04b609ae7db4addec24352a379cd167d5b149c6ef502ae16fe6ed131a71cc489
- journal
- abbreviation
- Blood
- issn electronic
- 1528-0020
- issn print
- 0006-4971
- issue
- 17
- name
- Blood
- nlm unique id
- 7603509
- pages
- 1903-1910
- volume
- 130
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Blood. 2017 Oct 26;130(17):1876-1877. doi: 10.1182/blood-2017-08-803551.
- note
- Source null
- related pmid
- 29074593
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 28819011
- provenance
- batch id
- fb25b16edcb1373b70c1
- provider
- NCBI PubMed ESummary
- record sha256
- 2ff3cc946f10511cc80a569473a988ba7ebc0c6073f8f953d4a6a4bcfc1ddbda
- response sha256
- 182c99bf1974b58308315b66aa28d31c61e8fc31cf3de4cadb0340a4f6734c52
- retrieved at
- 2026-09-09T23:47:28.490065+00:00
- publication date
- display
- 2017 Oct 26
- precision
- day
- year
- 2017
- publication types
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy.
Preserved source evidence · Not medical advice
Triangle